Core Viewpoint - BGI Genomics (688114.SH) has launched the T7+ ultra-high-throughput gene sequencer, which is currently the world's strongest daily delivery capacity sequencer, capable of producing over 14 terabases of data in 24 hours [1] Group 1: Product Features - The T7+ can complete a whole genome sequencing (WGS) every 10 minutes, with an annual processing capacity of up to 35,000 WGS [1] - The T7+ offers high accuracy and cost-effective large-scale sequencing, complementing the CycloneSEQ G400-ER platform, which provides ultra-long read sequencing [1] Group 2: Market Availability - The T7+ is available for immediate sale in mainland China, with shipments to Hong Kong, Macau, Taiwan, and overseas regions expected to begin in Q4 2025 [1]

人民财讯9月9日电，记者获悉，华大智造(688114)发布超高通量测序仪T7+。超高通量测序仪T7+可在24 小时内交付超14Tb的测序数据，平均每10分钟完成1例、每年完成高达35000例的人全基因组测序，打 破了高产与快速无法兼得的困境，刷新了规模测序极速。 ...

证券日报网讯 9月8日晚间，华大智造发布公告称，公司2025年第三次临时股东大会于2025年9月8日召 开，审议通过了《关于公司及摘要的议案》等多项议案。 （文章来源：证券日报） ...

北京市嘉源律师事务所 关于深圳华大智造科技股份有限公司 2025 年第三次临时股东大会的 法律意见书 西城区复兴门内大街 158 号远洋大厦 4 楼 中国·北京 班 邮 甲 直源律师事务所 IA YUAN LAW OFFICES 北京 BEIJING · 上海 SHANGHAI · 深圳 SHENZHEN · 香港 HONG KONG · 广州 GUANGZHOU · 西安 XI'AN 致:深圳华大智造科技股份有限公司 北京市嘉源律师事务所 关于深圳华大智造科技股份有限公司 2025 年第三次临时股东大会的 法律意见书 嘉源(2025)-04-640 北京市嘉源律师事务所(以下简称"本所")接受深圳华大智造科技股份有 限公司(以下简称"公司")的委托,根据《中华人民共和国公司法》(以下简 称"《公司法》")《上市公司股东会规则》(以下简称"《股东会规则》") 等现行有效的法律、行政法规、部门规章、规范性文件(以下简称"法律法规") 以及《深圳华大智造科技股份有限公司章程》（以下简称"《公司章程》"）的 有关规定,指派本所律师对公司2025年第三次临时股东大会(以下简称"本次股 东大会"）进行见证,并依法出具本 ...

证券代码：688114 证券简称：华大智造 公告编号：2025-058 深圳华大智造科技股份有限公司 2025年第三次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 9 月 8 日 （二） 股东大会召开的地点：深圳市盐田区梅沙街道云华路 9 号华大时空中心 C 区国际会议中心 419 会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 153 | | --- | --- | | 普通股股东人数 | 153 | | 2、出席会议的股东所持有的表决权数量 | 228,806,003 | | 普通股股东所持有表决权数量 | 228,806,003 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 55.4643 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比 ...

Core Viewpoint - The biopharmaceutical sector in China is experiencing a positive trend in innovation and investment, with significant growth in the approval of innovative drugs and a recovery in market conditions [1][2] Industry Summary - As of September 8, 2025, the Shanghai Stock Exchange Sci-Tech Innovation Board Biopharmaceutical Index (000683) increased by 0.89%, with notable gains from companies such as United Imaging Healthcare (688271) up 11.48% and BGI Genomics (688114) up 9.35% [1] - The "National Drug Safety Publicity Week" launched on September 1 highlights the positive development of the pharmaceutical industry, with 210 innovative drugs approved in the past five years, indicating a sustained growth trend [1] - Currently, approximately 30% of the world's innovative drugs under research are from China, showcasing the country's significant role in global pharmaceutical innovation [1] Company Summary - The top ten weighted stocks in the Sci-Tech Innovation Board Biopharmaceutical Index as of August 29, 2025, include United Imaging Healthcare (688271), BeiGene (688235), and others, collectively accounting for 50.27% of the index [2] - The Sci-Tech Biopharmaceutical ETF (588250) closely tracks the performance of the Sci-Tech Innovation Board Biopharmaceutical Index, reflecting the overall performance of representative biopharmaceutical companies listed on the Sci-Tech Board [2]

Group 1 - The medical device sector experienced a significant upward movement on September 8, with companies such as Aojing Medical, United Imaging Medical, and Kaili Medical seeing stock increases of over 10% [1] - Other companies in the sector, including Jimin Health, BGI Genomics, Dabo Medical, and Mindray Medical, also showed positive stock performance [1]

Domestic News - A total of 40 listed companies in the A-share market will have their restricted shares unlocked next week, with a combined market value of approximately 966.01 billion yuan. The companies with the highest unlock values include Times Electric (278.23 billion yuan), Southern Power Storage (230.81 billion yuan), and BGI Genomics (133.82 billion yuan) [1] - The unlock ratios for several companies exceed 50%, with Minshida at 66.23%, Southern Power Storage at 65.3%, Sailun Biotech at 59%, and Zhejiang Hengwei at 50.95% [1] International News - The 24th Economic Ministers' Meeting of the Shanghai Cooperation Organization (SCO) was held in Vladivostok, Russia, focusing on sustainable economic growth measures and planning for future regional economic cooperation [2] - The price of domestic gold jewelry has surpassed 1,060 yuan per gram, with brands like Chow Sang Sang and Lao Miao reporting increases in their gold prices [3] - The completion of the first main tower of the Zhuhai Bridge, which connects Zhoushan's Liuhong Island and Foduo Island, marks a significant milestone in infrastructure development, with a main span of 1,768 meters [3]

Core Viewpoint - The A-share market will see a significant unlock of restricted shares, totaling approximately 966.01 billion yuan, with 40 stocks experiencing share unlocks next week [2]. Group 1: Stock Unlock Details - 40 stocks will have their restricted shares unlocked from September 8 to 12, with a total unlock market value of 966.01 billion yuan [2]. - Among these, 12 stocks have an unlock market value exceeding 10 billion yuan, with notable mentions including Times Electric (278.23 billion yuan), Southern Network Storage (230.81 billion yuan), and BGI Genomics (133.82 billion yuan) [2][4]. - Southern Network Storage and Western Gold are among the stocks with restricted shares unlocked from directed placements, while the other three are from the initial public offering (IPO) original shareholders [2]. Group 2: Unlock Proportions - A total of 13 stocks have an unlock proportion exceeding 10%, indicating a potential impact on their stock prices [5]. - Stocks such as Minshida, Southern Network Storage, Sairun Bio, and Zhejiang Hengwei have unlock proportions above 50% [5]. - The detailed table lists various stocks, their unlock dates, market values, and the proportion of shares being unlocked [7]. Group 3: Company Performance Insights - Times Electric's largest shareholder, CRRC Zhuzhou Electric Locomotive Research Institute, will unlock approximately 590 million shares, accounting for 43.42% of the total share capital [4]. - Times Electric reported a revenue of 12.214 billion yuan for the first half of 2025, reflecting a year-on-year growth of 17.95%, with a net profit of 1.672 billion yuan, up 12.93% [4]. - Minshida, listed on the Beijing Stock Exchange, achieved a revenue of 237 million yuan in the first half of 2025, marking a year-on-year increase of 27.91%, with a net profit of 63.03 million yuan, up 42.28% [8]. Group 4: Institutional Investment Insights - Institutions that participated in the directed placements of stocks like Western Gold and Southern Network Storage are expected to see positive returns from the unlocks, with Western Gold's return exceeding 180% and Southern Network Storage's over 70% [8]. - Among the 40 stocks, 15 are categorized as general equity incentive shares or restricted shares, with companies like Sany Heavy Energy and Zhaoyi Innovation having unlock market values exceeding 1 billion yuan [8].

Summary of Key Points Core Viewpoint - The A-share market will see a significant unlock of restricted shares next week, with a total market value exceeding 96 billion yuan, which may impact stock prices of the affected companies [2]. Group 1: Unlock Scale and Impact - A total of 40 stocks will have their restricted shares unlocked from September 8 to 12, with a combined market value of 966.01 billion yuan [2]. - Among these, 12 stocks have an unlock market value exceeding 1 billion yuan, with notable companies like Times Electric, Southern Power Storage, and BGI Genomics having unlock values of 278.23 billion yuan, 230.81 billion yuan, and 133.82 billion yuan respectively [2][4]. Group 2: Unlock Proportions - Thirteen stocks have an unlock ratio exceeding 10%, indicating a potentially significant impact on their stock prices. Companies such as Minshida, Southern Power Storage, and Sailun Bio have unlock ratios above 50% [5]. - The highest unlock ratio is seen in Minshida at 66.23%, followed by Southern Power Storage at 65.30% and Sailun Bio at 59.00% [7]. Group 3: Company Performance - Times Electric's major shareholder, CRRC Zhuzhou Electric Locomotive Research Institute, will unlock approximately 590 million shares, accounting for 43.42% of its total share capital. The company reported a revenue of 12.214 billion yuan for the first half of 2025, a year-on-year increase of 17.95%, and a net profit of 1.672 billion yuan, up 12.93% [4]. - Minshida, listed on the Beijing Stock Exchange, achieved a revenue of 237 million yuan in the first half of 2025, reflecting a year-on-year growth of 27.91%, with a net profit of 63.03 million yuan, up 42.28% [8]. Group 4: Institutional Investment Returns - Institutions that participated in the private placements of stocks like Western Gold and Southern Power Storage are expected to see positive returns from the unlock, with Western Gold's return exceeding 180% and Southern Power Storage's over 70% [8].